Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Szilágyi Melinda

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2008-2026

2026

Csók, Á., Micsik, T., Magyar, Z., Tornóczky, T., Kuthi, L., Kabai, A. B., Szirák, K., Szilágyi, M., Csóka, M., Ottóffy, G., Soltész, B., Balogh, I., Buglyó, G.: Patterns of miRNA Expression in Primary and Metastatic Wilms Tumor.
Med. Sci. Monitor. 32, 1-22, (article identifier: 952424), 2026.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous) (2025)

2025

Géczi, D., Klekner, Á., Balogh, I., Penyige, A., Szilágyi, M., Virga, J., Bakó, A., Nagy, B., Torner, B., Hádáné Birkó, Z.: Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing.
Pharmaceuticals. 18 (3), 1-29, (article identifier: 431), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

Márton, É., Beke-Varga, A. E., Domoszlai, D., Buglyó, G., Balázs, A., Penyige, A., Balogh, I., Nagy, B., Szilágyi, M.: Non-Coding RNAs in Cancer: structure, Function, and Clinical Application.
Cancers (Basel). 17 (4), 1-41, (article identifier: 579), 2025.

doi DEA WoS

Journal metrics:

Q2 Cancer Research

Q1 Oncology

2023

Márton, É., Beke-Varga, A. E., Penyige, A., Hádáné Birkó, Z., Balogh, I., Nagy, B., Szilágyi, M.: Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells.
Toxins. 15 (2), 1-22, (article identifier: 140), 2023.

doi DEA Scopus

Journal metrics:

Q1 Health, Toxicology and Mutagenesis

Q1 Toxicology

2022

Beke-Varga, A. E., Márton, É., Markovics, A., Penyige, A., Balogh, I., Nagy, B., Szilágyi, M.: Suppressing the PI3K/AKT Pathway by miR-30d-5p Mimic Sensitizes Ovarian Cancer Cells to Cell Death Induced by High-Dose Estrogen.
Biomedicines. 10 (9), 1-19, (article identifier: 2060), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

Soltész, B., Buglyó, G., Németh, N., Szilágyi, M., Pös, O., Szemes, T., Balogh, I., Nagy, B.: The Role of Exosomes in Cancer Progression.
Int. J. Mol. Sci. 23 (1), 1-19, (article identifier: 8), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2021

Géczi, D., Nagy, B., Szilágyi, M., Penyige, A., Klekner, Á., Jenei, A., Virga, J., Hádáné Birkó, Z.: Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients.
Int. J. Mol. Sci. 22 (10), 1-20, (article identifier: 5058), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

Márton, É., Beke-Varga, A. E., Soltész, B., Penyige, A., Lukács, J., Póka, R., Nagy, B., Szilágyi, M.: Comparative Analysis of Cell-Free miR-205-5p, let-7f-5p, and miR-483-5p Expression in Ovarian Cell Cultures and Plasma Samples of Patients with Ovarian Cancer.
Appl. Sci.-Basel. 11 (4), 1-10, 2021.

doi DEA WoS Scopus

Journal metrics:

Q3 Computer Science Applications

Q2 Engineering (miscellaneous)

Q2 Fluid Flow and Transfer Processes

Q2 Instrumentation

Q2 Materials Science (miscellaneous)

Q2 Process Chemistry and Technology

2020

Szilágyi, M., Pös, O., Márton, É., Buglyó, G., Soltész, B., Keserű, J., Penyige, A., Szemes, T., Nagy, B.: Circulating cell-free nucleic acids: main characteristics and clinical application.
Int. J. Mol. Sci. 21 (18), 1-20, (article identifier: 6827), 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

10.

Márton, É., Beke-Varga, A. E., Széles, L., Göczi, L., Penyige, A., Nagy, B., Szilágyi, M.: The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells.
Int. J. Mol. Sci. 21 (24), 1-19, (article identifier: 9725), 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

2019

11.

Márton, É., Lukács, J., Penyige, A., Janka, E. A., Hegedüs, L., Soltész, B., Méhes, G., Póka, R., Nagy, B., Szilágyi, M.: Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer.
J. Biotechnol. 297, 58-65, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Applied Microbiology and Biotechnology

Q2 Bioengineering

Q1 Biotechnology

Q1 Medicine (miscellaneous)

12.

Penyige, A., Márton, É., Soltész, B., Szilágyi, M., Póka, R., Lukács, J., Széles, L., Nagy, B.: Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients.
Int. J. Mol. Sci. 20 (18), E4533, (article identifier: 4533), 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

Q1 Spectroscopy

13.

Keserű, J., Soltész, B., Lukács, J., Márton, É., Szilágyi, M., Penyige, A., Póka, R., Nagy, B.: Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer.
J. Biotechnol. 298, 76-81, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Applied Microbiology and Biotechnology

Q2 Bioengineering

Q1 Biotechnology

Q1 Medicine (miscellaneous)

14.

Soltész, B., Lukács, J., Szilágyi, E., Márton, É., Szilágyi, M., Penyige, A., Póka, R., Nagy, B.: Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
J. Biotechnol. 298, 16-20, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Applied Microbiology and Biotechnology

Q2 Bioengineering

Q1 Biotechnology

Q1 Medicine (miscellaneous)

2018

15.

Soltész, B., Lukács, J., Márton, É., Szilágyi, M., Penyige, A., Póka, R., Nagy, B.: A CD24 mRNS-expresszió meghatározása kvantitatív valósidejű PCR-módszerrel alacsonyan differenciált szerózus papilláris petefészekrákos szöveti mintákból.
Magyar Nőorv. L. 81 (5), 254-258, 2018.

DEA

16.

Szilágyi, M., Anton, F., Pócsi, I., Emri, T.: Autolytic enzymes are responsible for increased melanization of carbon stressed Aspergillus nidulans cultures.
J. Basic Microbiol. 58 (5), 440-447, 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Applied Microbiology and Biotechnology

Q2 Medicine (miscellaneous)

17.

Szilágyi, M., Márton, É., Lukács, J., Soltész, B., Janka, E. A., Penyige, A., Póka, R., Nagy, B.: MiR200a, miR200b and miR200c are promising candidate biomarkers in epithelial ovarian cancer.
Biomedical Papers. 162 (Suppl.), S11, 2018.

DEA

18.

Szilágyi, M., Márton, É., Lukács, D., Hádáné Birkó, Z., Kele, Z., Biró, S.: Mutation in afsR Leads to A-Factor Deficiency in Streptomyces griseus B2682.
J. Mol. Microbiol. Biotechnol. 28 (5), 216-224, 2018.

doi DEA

Journal metrics:

Q3 Applied Microbiology and Biotechnology

Q2 Biotechnology

Q3 Microbiology

Q4 Molecular Biology

19.

Márton, É., Lukács, J., Szabó, R., Soltész, B., Janka, E. A., Póka, R., Nagy, B., Szilágyi, M.: Study the role of miR141 and miR429 in the diagnosis of epithelial ovarian cancer.
Biomedical Papers. 162 (Suppl.), S17, 2018.

DEA

2016

20.

van Munster, J. M., Burggraaf, A. M., Pócsi, I., Szilágyi, M., Emri, T., Ram, A. F.: Post-genomic Approaches to Dissect Carbon Starvation Responses in Aspergilli.
In: Aspergillus and Penicillium in the Post-genomic Era. Ed.: Ronald P. de Vries, Isabelle Benoit Gelber, Mikael Rørdam Andersen, Caister Academic Press, Norfolk, 89-111, 2016. ISBN: 9781910190395

DEA

2015

21.

Spitzmüller, Z., Kwon, N. J., Szilágyi, M., Keserű, J., Tóth, V., Yu, J. H., Pócsi, I., Emri, T.: [Gamma]-Glutamyl transpeptidase (GgtA) of Aspergillus nidulans is not necessary for bulk degradation of glutathione.
Arch. Microbiol. 197 (2), 285-297, 2015.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry

Q3 Genetics

Q2 Medicine (miscellaneous)

Q3 Microbiology

Q3 Molecular Biology

2013

22.

Yin, W. B., Reinke, A. W., Szilágyi, M., Emri, T., Chiang, Y. M., Keating, A. E., Pócsi, I., Wang, C. C. C., Keller, N. P.: bZIP transcription factors affecting secondary metabolism, sexual development and stress responses in Aspergillus nidulans.
Microbiology (Reading, Engl.). 159 (Pt_1), 77-88, 2013.

doi DEA

Journal metrics:

Q1 Microbiology

23.

Tóth, V., Szilágyi, M., Anton, F., Leiter, É., Pócsi, I., Emri, T.: Interactions between naturally occurring antifungal agents: short communication.
Acta Biol. Hung. 64 (4), 510-512, 2013.

doi DEA

Journal metrics:

Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q3 Environmental Science (miscellaneous)

Q3 Neurology

24.

Szilágyi, M., Miskei, M., Karányi, Z., Lenkey, B., Pócsi, I., Emri, T.: Transcriptome changes initiated by carbon starvation in Aspergillus nidulans.
Microbiology (Reading, Engl.). 159 (1), 176-190, 2013.

doi DEA

Journal metrics:

Q1 Microbiology

2012

25.

Szilágyi, M., Anton, F., Forgács, K., Yu, J. H., Pócsi, I., Emri, T.: Antifungal activity of extracellular hydrolases produced by autolysing Aspergillus nidulans cultures.
J. Microbiol. 50 (5), 849-854, 2012.

doi DEA

Journal metrics:

Q2 Applied Microbiology and Biotechnology

Q2 Medicine (miscellaneous)

Q3 Microbiology